Tacrolimus Drug–Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin

INTRODUCTION: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) pandemic has had a significant impact on communities and health systems. The Federal Drug Administration (FDA) authorized Pfizer’s nirmatrelvir/ritonavir (Paxlovid™) through an EUA for the treatment of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Sindelar, Morganne, McCabe, Daniel, Carroll, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762866/
https://www.ncbi.nlm.nih.gov/pubmed/36536192
http://dx.doi.org/10.1007/s13181-022-00922-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762866/
https://www.ncbi.nlm.nih.gov/pubmed/36536192
http://dx.doi.org/10.1007/s13181-022-00922-2

Ejemplares similares